Quick answer: No. Hydroxyzine, a prescription antihistamine, is not one of the drugs a standard 10-panel urine drug test is designed to detect. Rarely, it may contribute to a presumptive false positive on some immunoassay screens, so any non-negative result should be confirmed by laboratory GC-MS or LC-MS/MS before action is taken.
- Hydroxyzine is not a target analyte on any common 10-panel configuration.
- Instant screens are presumptive; cross-reactivity is possible, so confirmation is the safeguard.
- Cutoffs and panel makeup vary by manufacturer, so read each device insert.
What a 10-panel test actually detects
A 10-panel urine test checks for ten drug classes. The exact list varies by manufacturer, but a common configuration includes amphetamines, barbiturates, benzodiazepines, cocaine, marijuana (THC), methadone, methaqualone or MDMA, opiates, phencyclidine (PCP) and oxycodone or propoxyphene. Antihistamines such as hydroxyzine are not on that list.
Need drug tests for your clinic, program or workplace?
American Screening Corp has supplied FDA-cleared, CLIA-waived tests at wholesale pricing since 2004. Popular options:
- 10-panel drug test cups and dip cards
- 12-panel drug test cups
- all drug test cups (wholesale pricing)
Ordering 100+ tests? Request volume pricing.
The panel uses immunoassay chemistry. Antibodies bind to a drug or its metabolite, and the device reports a result when the concentration is above a set cutoff. Because the antibodies recognize chemical structure rather than a specific drug name, a structurally similar compound can occasionally trigger a reaction.
Typical cutoff levels
The HHS Mandatory Guidelines for federal workplace programs (SAMHSA) set initial urine cutoffs of 50 ng/mL for marijuana metabolite, 150 ng/mL for cocaine metabolite, 500 ng/mL for amphetamines, 2,000 ng/mL for opiates and 25 ng/mL for PCP. Benzodiazepines, barbiturates, methadone and oxycodone are not in the federal five-drug panel, so non-regulated cups use manufacturer-specific cutoffs, commonly 300 ng/mL for benzodiazepines, though this varies by product. Confirm the numbers on the insert for the lot you buy.
| Scenario | What it means | Recommended action |
|---|---|---|
| Negative on all ten panels | No target drug above cutoff | Document per your policy |
| Non-negative, donor reports hydroxyzine | Possible cross-reactivity, but not assumed | Send to lab for GC-MS or LC-MS/MS confirmation |
| Non-negative, no explanation | Presumptive positive | Send to lab for confirmation and MRO review where applicable |
| Invalid or dilute specimen | Result unreliable | Recollect per your protocol |
Why hydroxyzine raises questions
Hydroxyzine is prescribed for anxiety, itching and sedation, according to MedlinePlus (National Library of Medicine). Donors on it often disclose it at collection. Because it is a sedating, structurally complex compound, some immunoassays have been reported to react to it or similar drugs. Reports are inconsistent and depend on the assay, so treat any such reaction as a reason to confirm rather than as a conclusion.
Confirmation is the deciding step
GC-MS and LC-MS/MS identify specific molecules instead of structural families. If hydroxyzine caused the screen reaction, confirmation will not find the target drug, and the result is reported as negative. This is why instant results should never be the sole basis for an adverse decision.
How to read and handle results
- Check the specimen first: temperature window, no tampering signs and a valid collection.
- Read the result within the time window in the device instructions. Ignore lines that develop later.
- On most cups, a line in the control and test region means negative; no line in a drug region means a non-negative presumptive result. Verify against the insert.
- Record the result and device lot number.
- Seal and send non-negative specimens for laboratory confirmation.
Choosing devices for your program
Programs that screen on site typically choose between a multi-panel drug test cup with built-in temperature strips and a drug test dip card for lower-cost, high-volume screening. Either way, check the packaging for FDA 510(k) clearance and CLIA-waived status, which differ by product and panel. Do not assume a device is cleared for point-of-care use unless the documentation says so. If you need help matching a panel to your policy, contact American Screening Corp.
Checklist for non-negative results
- Confirm the panel configuration and cutoffs on the device insert.
- Ask the donor to disclose medications on the custody form, not to justify a result on the spot.
- Never treat a presumptive result as final.
- Send non-negative specimens for GC-MS or LC-MS/MS confirmation.
- Route confirmed results through a Medical Review Officer where your program uses one.
- Apply your written policy consistently to every donor.
- For DOT-regulated testing, follow 49 CFR Part 40; non-DOT 10-panel cups are not a substitute.
Employers who pair testing with hiring should keep drug screening separate from background screening; Reveal Background handles the latter.
Frequently asked questions
Does hydroxyzine show up on a 10 panel drug test?
No. It is not a target analyte on standard 10-panel cups. Rare cross-reactivity on some immunoassays is possible, so confirm any non-negative result in a lab.
Can hydroxyzine cause a false positive?
It has been discussed as a possible cross-reactant on some screening assays, though evidence varies by test. Confirmation testing resolves it.
What confirms a presumptive positive?
GC-MS or LC-MS/MS laboratory testing identifies the specific substance and concentration, replacing the screen's structural-match approach.
Is a 10 panel cup valid for DOT testing?
No. DOT testing under 49 CFR Part 40 requires a federal custody and control form, a certified laboratory and a defined panel. Instant cups are for non-DOT programs.
Sources
- MedlinePlus (NLM): Hydroxyzine
- SAMHSA: Workplace Drug Testing and Mandatory Guidelines
- U.S. DOT ODAPC: 49 CFR Part 40
This article is general information, not legal or medical advice.
